Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 15Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 5Head and Neck Neoplasms 4Lung Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Neuroblastoma 2Adenocarcinoma 2Wilms Tumor 1Stomatitis 1Squamous Cell Cancer of Head and Neck (SCCHN) 1Skin Neoplasms 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdoid Tumor 1Recurrence 1Radiation Injuries 1Prostate Cancer Metastatic 1Prostate Adenocarcinoma 1Pelvic Neoplasms 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1

Interventions

Gemcitabine 82Cisplatin 52Oxaliplatin 36lenvatinib 24durvalumab 22Capecitabine 22Fluorouracil 20Leucovorin 15tislelizumab 11pembrolizumab 10apatinib 10Radiotherapy 10Albumin-Bound Paclitaxel 10Radiofrequency Ablation 9Magnetic Resonance Spectroscopy 9Irinotecan 9Floxuridine 9Liver Transplantation 8Drug Therapy 8Cholangiopancreatography, Endoscopic Retrograde 8130-nm albumin-bound paclitaxel 8Taxes 7Platinum 7Photochemotherapy 7Panitumumab 7Biopsy 71,2-diaminocyclohexaneplatinum II citrate 7tremelimumab 6pemigatinib 6camrelizumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cholangiocarcinoma × Radiotherapy, Image-Guided × Clear all
NCT02200042 2026-05-19

Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer

NRG Oncology

Phase 3 Terminated
1 enrolled 5 charts
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡